Cargando…

Self-assembly of cholesterol end-capped polymer micelles for controlled drug delivery

BACKGROUND: During the past few decades, drug delivery system (DDS) has attracted many interests because it could enhance the therapeutic effects of drugs and reduce their side effects. The advent of nanotechnology has promoted the development of nanosized DDSs, which could promote drug cellular upt...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Ming, Yang, Yifeng, Bergfel, Andreas, Huang, Lanli, Zheng, Li, Bowden, Tim Melander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964014/
https://www.ncbi.nlm.nih.gov/pubmed/31941501
http://dx.doi.org/10.1186/s12951-020-0575-y
_version_ 1783488414360797184
author Gao, Ming
Yang, Yifeng
Bergfel, Andreas
Huang, Lanli
Zheng, Li
Bowden, Tim Melander
author_facet Gao, Ming
Yang, Yifeng
Bergfel, Andreas
Huang, Lanli
Zheng, Li
Bowden, Tim Melander
author_sort Gao, Ming
collection PubMed
description BACKGROUND: During the past few decades, drug delivery system (DDS) has attracted many interests because it could enhance the therapeutic effects of drugs and reduce their side effects. The advent of nanotechnology has promoted the development of nanosized DDSs, which could promote drug cellular uptake as well as prolong the half-life in blood circulation. Novel polymer micelles formed by self-assembly of amphiphilic polymers in aqueous solution have emerged as meaningful nanosystems for controlled drug release due to the reversible destabilization of hydrophobic domains under different conditions. RESULTS: The amphiphilic polymers presented here were composed of cholesterol groups end capped and poly (poly (ethylene glycol) methyl ether methacrylate) (poly (OEGMA)) as tailed segments by the synthesis of cholesterol-based initiator, followed by atom transfer radical polymerization (ATRP) with OEGMA monomer. FT-IR and NMR confirmed the successfully synthesis of products including initiator and polymers as well as the Mw of the polymers were from 33,233 to 89,088 g/mol and their corresponding PDI were from 1.25 to 1.55 by GPC. The average diameter of assembled polymer micelles was in hundreds nanometers demonstrated by DLS, AFM and SEM. The behavior of the amphiphilic polymers as micelles was investigated using pyrene probing to explore their critical micelle concentration (CMC) ranging from 2.53 × 10(−4) to 4.33 × 10(−4) mg/ml, decided by the balance between cholesterol and poly (OEGMA). Besides, the CMC of amphiphilic polymers, the quercetin (QC) feeding ratio and polarity of solvents determined the QC loading ratio maximized reaching 29.2% certified by UV spectrum, together with the corresponding size and stability changes by DLS and Zeta potential, and thermodynamic changes by TGA and DSC. More significantly, cholesterol end-capped polymer micelles were used as nanosized systems for controlled drug release, not only alleviated the cytotoxicity of QC from 8.6 to 49.9% live cells and also achieved the QC release in control under different conditions, such as the presence of cyclodextrin (CD) and change of pH in aqueous solution. CONCLUSIONS: The results observed in this study offered a strong foundation for the design of favorable polymer micelles as nanosized systems for controlled drug release, and the molecular weight adjustable amphiphilic polymer micelles held potential for use as controlled drug release system in practical application.
format Online
Article
Text
id pubmed-6964014
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69640142020-01-22 Self-assembly of cholesterol end-capped polymer micelles for controlled drug delivery Gao, Ming Yang, Yifeng Bergfel, Andreas Huang, Lanli Zheng, Li Bowden, Tim Melander J Nanobiotechnology Research BACKGROUND: During the past few decades, drug delivery system (DDS) has attracted many interests because it could enhance the therapeutic effects of drugs and reduce their side effects. The advent of nanotechnology has promoted the development of nanosized DDSs, which could promote drug cellular uptake as well as prolong the half-life in blood circulation. Novel polymer micelles formed by self-assembly of amphiphilic polymers in aqueous solution have emerged as meaningful nanosystems for controlled drug release due to the reversible destabilization of hydrophobic domains under different conditions. RESULTS: The amphiphilic polymers presented here were composed of cholesterol groups end capped and poly (poly (ethylene glycol) methyl ether methacrylate) (poly (OEGMA)) as tailed segments by the synthesis of cholesterol-based initiator, followed by atom transfer radical polymerization (ATRP) with OEGMA monomer. FT-IR and NMR confirmed the successfully synthesis of products including initiator and polymers as well as the Mw of the polymers were from 33,233 to 89,088 g/mol and their corresponding PDI were from 1.25 to 1.55 by GPC. The average diameter of assembled polymer micelles was in hundreds nanometers demonstrated by DLS, AFM and SEM. The behavior of the amphiphilic polymers as micelles was investigated using pyrene probing to explore their critical micelle concentration (CMC) ranging from 2.53 × 10(−4) to 4.33 × 10(−4) mg/ml, decided by the balance between cholesterol and poly (OEGMA). Besides, the CMC of amphiphilic polymers, the quercetin (QC) feeding ratio and polarity of solvents determined the QC loading ratio maximized reaching 29.2% certified by UV spectrum, together with the corresponding size and stability changes by DLS and Zeta potential, and thermodynamic changes by TGA and DSC. More significantly, cholesterol end-capped polymer micelles were used as nanosized systems for controlled drug release, not only alleviated the cytotoxicity of QC from 8.6 to 49.9% live cells and also achieved the QC release in control under different conditions, such as the presence of cyclodextrin (CD) and change of pH in aqueous solution. CONCLUSIONS: The results observed in this study offered a strong foundation for the design of favorable polymer micelles as nanosized systems for controlled drug release, and the molecular weight adjustable amphiphilic polymer micelles held potential for use as controlled drug release system in practical application. BioMed Central 2020-01-15 /pmc/articles/PMC6964014/ /pubmed/31941501 http://dx.doi.org/10.1186/s12951-020-0575-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gao, Ming
Yang, Yifeng
Bergfel, Andreas
Huang, Lanli
Zheng, Li
Bowden, Tim Melander
Self-assembly of cholesterol end-capped polymer micelles for controlled drug delivery
title Self-assembly of cholesterol end-capped polymer micelles for controlled drug delivery
title_full Self-assembly of cholesterol end-capped polymer micelles for controlled drug delivery
title_fullStr Self-assembly of cholesterol end-capped polymer micelles for controlled drug delivery
title_full_unstemmed Self-assembly of cholesterol end-capped polymer micelles for controlled drug delivery
title_short Self-assembly of cholesterol end-capped polymer micelles for controlled drug delivery
title_sort self-assembly of cholesterol end-capped polymer micelles for controlled drug delivery
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964014/
https://www.ncbi.nlm.nih.gov/pubmed/31941501
http://dx.doi.org/10.1186/s12951-020-0575-y
work_keys_str_mv AT gaoming selfassemblyofcholesterolendcappedpolymermicellesforcontrolleddrugdelivery
AT yangyifeng selfassemblyofcholesterolendcappedpolymermicellesforcontrolleddrugdelivery
AT bergfelandreas selfassemblyofcholesterolendcappedpolymermicellesforcontrolleddrugdelivery
AT huanglanli selfassemblyofcholesterolendcappedpolymermicellesforcontrolleddrugdelivery
AT zhengli selfassemblyofcholesterolendcappedpolymermicellesforcontrolleddrugdelivery
AT bowdentimmelander selfassemblyofcholesterolendcappedpolymermicellesforcontrolleddrugdelivery